---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-109893"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:48:47.044090+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Petros Pharma reduces President Boctor's base salary to $280K, sets Dec 31 termination

## Summary
- Base salary cut from $350K to $280K effective Oct 16, 2024.
- Employment termination date set to Dec 31, 2024; at-will status continues.
- Boctor now permitted to engage in other consulting/employment activities if no conflict.
- Amendment approved by Director Josh Silverman.

## SEC filing metadata
- accession: 0001104659-24-109893
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465924109893/0001104659-24-109893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465924109893/tm2426328d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-109893
- JSON: https://secwatch.observer/filing/0001104659-24-109893.json
- Plain text: https://secwatch.observer/filing/0001104659-24-109893.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.